Live Breaking News & Updates on Tom zhang

Stay informed with the latest breaking news from Tom zhang on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Tom zhang and stay connected to the pulse of your community

THYSSENKRUPP : Barclays keeps a Sell rating

Tom Zhang from Barclays retains his negative opinion on the stock with a Sell rating. The target price is reduced from EUR 7 to EUR 5.

Tom-zhang , Barclays ,

ARCELORMITTAL : Barclays reiterates its Neutral rating

Analyst Tom Zhang from Barclays research gives the stock a Neutral rating. The target price is decreased from EUR 27 to EUR 26.

Tom-zhang , Barclays , Analyst-tom-zhang ,

HEIDELBERG MATERIALS : Barclays maintains a Buy rating -February 23, 2024 at 06:59 am EST

Barclays analyst Tom Zhang maintains his Buy rating on the stock. The target price is still set at EUR 106.

Tom-zhang , Barclays , Markets ,

Barclays raises Heidelberg Materials to 'Overweight'

The British investment bank Barclays has upgraded Heidelberg Materials from Underweight to Overweight and raised its price target from 70 to 106 euros. The improved pricing power of European building...

London , City-of , United-kingdom , British , Tom-zhang , Barclays , Heidelberg-materials , Markets ,

THYSSENKRUPP : Barclays gives a Sell rating -February 14, 2024 at 10:04 am EST

Barclays analyst Tom Zhang reiterate his Sell rating on the stock. The target price is still set at EUR 7.

Tom-zhang , Barclays , Markets ,

ARCELORMITTAL : Barclays sticks Neutral -February 09, 2024 at 10:18 am EST

In a research note, Barclays analyst Tom Zhang has maintained his recommendation on the stock with a Neutral rating. The target price remains set at EUR 27.

Tom-zhang , Barclays , Markets ,

Revolutionizing clinical trials: Unlocking peak efficiency with total laboratory automation in bioanalysis

BioPharma

Tom-zhang , Lab-automation , Total-lab-automation , Clinical-trials ,

THYSSENKRUPP : Barclays reaffirms its Sell rating -November 28, 2023 at 02:59 am EST

In his latest research note, analyst Tom Zhang confirms his negative recommendation. The broker Barclays is keeping its Sell rating. The target price continues to be set at EUR 7.

Tom-zhang , Barclays , Markets ,

Barclays rates Thyssenkrupp at 'Underweight' - Target 7 euros

The British investment bank Barclays has left its rating for Thyssenkrupp at Underweight with a target price of 7 euros. The steel business was weak, wrote analyst Tom Zhang on Wednesday morning after...

United-kingdom , London , City-of , British , Barclays , Tom-zhang , Markets ,

ARCELORMITTAL : Gets a Neutral rating from Barclays -November 10, 2023 at 10:31 am EST

In a research note, Barclays analyst Tom Zhang has maintained his recommendation on the stock with a Neutral rating. The target price is still set at EUR 27.

Tom-zhang , Barclays , Markets ,

Live Breaking News & Updates on Tom zhang

Tom Zhang from Barclays retains his negative opinion on the stock with a Sell rating. The target price is reduced from EUR 7 to EUR 5.Tom-zhang , Barclays ,

Analyst Tom Zhang from Barclays research gives the stock a Neutral rating. The target price is decreased from EUR 27 to EUR 26.Tom-zhang , Barclays , Analyst-tom-zhang ,

Barclays analyst Tom Zhang maintains his Buy rating on the stock. The target price is still set at EUR 106.Tom-zhang , Barclays , Markets ,

Barclays analyst Tom Zhang reiterate his Sell rating on the stock. The target price is still set at EUR 7.Tom-zhang , Barclays , Markets ,

In a research note, Barclays analyst Tom Zhang has maintained his recommendation on the stock with a Neutral rating. The target price remains set at EUR 27.Tom-zhang , Barclays , Markets ,

BioPharmaTom-zhang , Lab-automation , Total-lab-automation , Clinical-trials ,

In his latest research note, analyst Tom Zhang confirms his negative recommendation. The broker Barclays is keeping its Sell rating. The target price continues to be set at EUR 7.Tom-zhang , Barclays , Markets ,

The British investment bank Barclays has left its rating for Thyssenkrupp at Underweight with a target price of 7 euros. The steel business was weak, wrote analyst Tom Zhang on Wednesday morning after...United-kingdom , London , City-of , British , Barclays , Tom-zhang , Markets ,

In a research note, Barclays analyst Tom Zhang has maintained his recommendation on the stock with a Neutral rating. The target price is still set at EUR 27.Tom-zhang , Barclays , Markets ,